Require An Uncommon Approach
Uncommon Cures Require An Uncommon Approach
Clinical Trial Innovation
Introducing Uncommon Cures
Revolutionizing Rare Disease Clinical Research
Uncommon Cures Require Uncommon Thinking
Our Dual Apporach
Our unique dual approach combines the centralization of high-risk clinical operations and the decentralization of low-risk clinical operations. This strategy streamlines processes, reduces costs, and maintains the highest quality of patient care throughout the clinical trial lifecycle.
Centralize High-risk Clinical Operations at a Single Location
De-centralize Low-Risk Clinical Operations to Home-Based Solutions
Pioneering Rare Disease Clinical Research Solutions
What We Do
Meet Our Leaders
Marshall Summar, MD
Chief Executive Officer
Dr. Summar is well-known for his pioneering work in caring for children diagnosed with rare diseases. He is now the Chief Executive Officer of Uncommon Cures, LLC, a rare disease clinical trials company focused on physically consolidating trials and using innovative technology to reduce time and cost.